ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HIT vs RDZN // EV/EBITDA & P/E VALUATION

Health In Tech Inc. (Class A) (NASDAQ) VS. Roadzen Inc. (NASDAQ) • 15-METRIC TALLY: HIT 5 — RDZN 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HIT VS. RDZN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HIT RDZN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 7.50% -35.00% +42.50 HIT /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield 7.85% -21.25% +29.10 HIT /fcf-yield <GO>
Operating Margin — -25.40% — TIE /operating-margins <GO>
Net Profit Margin 3.80% -40.90% +44.70 HIT /net-margins <GO>
Revenue Growth (YoY) 71.00% 24.20% +46.80 HIT /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 3/9 +4.00 HIT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.3 48.6 -11.30 RDZN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 26.2x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $39.9M $95.4M -$55.4M RDZN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HIT REV RDZN REV HIT GROSS % RDZN GROSS % HIT FCF RDZN FCF
FY 2025 $33.3M $55.0M — — $3.1M -$20.3M
FY 2024 $19.5M $44.3M — — $2.2M -$18.1M
FY 2023 $19.2M $46.7M — — $1.5M -$19.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HIT // BETA —
RDZN // BETA —